PMID- 29858545 OWN - NLM STAT- MEDLINE DCOM- 20190507 LR - 20240328 IS - 2162-3279 (Electronic) VI - 8 IP - 7 DP - 2018 Jul TI - Impact of brain-derived neurotrophic factor genetic polymorphism on cognition: A systematic review. PG - e01009 LID - 10.1002/brb3.1009 [doi] LID - e01009 AB - INTRODUCTION: Brain-derived neurotrophic factor (BDNF) has an important role in the neurogenesis and neuroplasticity of the brain. This systematic review was designed to examine the association between BDNF Val66Met (rs6265) polymorphism and four cognitive domains-attention and concentration, executive function, verbal fluency, and memory, respectively. METHODOLOGY: Primary literature search was performed using search engines such as PubMed and Scopus. Observational studies that evaluated the neurocognitive performances in relation to BDNF polymorphism within human subjects were included in this review, while animal studies, overlapping studies, and meta-analysis were excluded. RESULTS: Forty of 82 reviewed studies (48.8%) reported an association between Val66Met polymorphism and neurocognitive domains. The proportion of the studies showing positive findings in cognitive performances between Val/Val homozygotes and Met carriers was comparable, at 30.5% and 18.3%, respectively. The highest percentage of positive association between Val66Met polymorphism and neurocognition was reported under the memory domain, with 26 of 63 studies (41.3%), followed by 18 of 47 studies (38.3%) under the executive function domain and four of 23 studies (17.4%) under the attention and concentration domain. There were no studies showing an association between Val66Met polymorphism and verbal fluency. In particular, Val/Val homozygotes performed better in tasks related to the memory domain, while Met carriers performed better in terms of executive function, in both healthy individuals and clinical populations. CONCLUSION: While numerous studies report an association between Val66Met polymorphism and neurocognitive changes in executive function and memory domains, the effect of Met allele has not been clearly established. CI - (c) 2018 The Authors. Brain and Behavior published by Wiley Periodicals, Inc. FAU - Toh, Yi Long AU - Toh YL AUID- ORCID: 0000-0003-2997-555X AD - Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore. FAU - Ng, Terence AU - Ng T AD - Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore. FAU - Tan, Megan AU - Tan M AD - Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore. FAU - Tan, Azrina AU - Tan A AD - Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore. FAU - Chan, Alexandre AU - Chan A AD - Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore. AD - Department of Pharmacy, National Cancer Centre Singapore, Singapore, Singapore. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Systematic Review DEP - 20180601 PL - United States TA - Brain Behav JT - Brain and behavior JID - 101570837 RN - 0 (Brain-Derived Neurotrophic Factor) SB - IM MH - Adult MH - Alleles MH - Brain MH - Brain-Derived Neurotrophic Factor/*genetics MH - Cognition/*physiology MH - Cognition Disorders/*genetics MH - Female MH - Genotype MH - Humans MH - Male MH - Middle Aged MH - Polymorphism, Genetic/*genetics PMC - PMC6043712 OTO - NOTNLM OT - attention OT - brain-derived neurotrophic factor OT - executive control OT - memory OT - neuroprotection EDAT- 2018/06/03 06:00 MHDA- 2019/05/08 06:00 PMCR- 2018/06/01 CRDT- 2018/06/03 06:00 PHST- 2017/07/30 00:00 [received] PHST- 2018/04/08 00:00 [revised] PHST- 2018/04/15 00:00 [accepted] PHST- 2018/06/03 06:00 [pubmed] PHST- 2019/05/08 06:00 [medline] PHST- 2018/06/03 06:00 [entrez] PHST- 2018/06/01 00:00 [pmc-release] AID - BRB31009 [pii] AID - 10.1002/brb3.1009 [doi] PST - ppublish SO - Brain Behav. 2018 Jul;8(7):e01009. doi: 10.1002/brb3.1009. Epub 2018 Jun 1.